{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:26:26Z","timestamp":1792481186800,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["24B310001"],"award-info":[{"award-number":["24B310001"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004773","name":"Henan University","doi-asserted-by":"publisher","award":["HUSSYS2024001"],"award-info":[{"award-number":["HUSSYS2024001"]}],"id":[{"id":"10.13039\/501100004773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["252102310338"],"award-info":[{"award-number":["252102310338"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011447","name":"Science and Technology Department of Henan Province","doi-asserted-by":"publisher","award":["242102310194"],"award-info":[{"award-number":["242102310194"]}],"id":[{"id":"10.13039\/501100011447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.cellsig.2025.111869","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T10:59:19Z","timestamp":1747220359000},"page":"111869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Role of ferroptosis in breast cancer: Molecular mechanisms and therapeutic interventions"],"prefix":"10.1016","volume":"134","author":[{"given":"Bo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Mei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Fen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2025.111869_bb0005","doi-asserted-by":"crossref","first-page":"1440430","DOI":"10.3389\/fgene.2024.1440430","article-title":"Management of triple-negative breast cancer by natural compounds through different mechanistic pathways","volume":"15","author":"Kaleem","year":"2024","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111869_bb0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2741\/4847","article-title":"Epigenetic alterations in cancer","volume":"25","author":"Ilango","year":"2020","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cellsig.2025.111869_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111869_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif."},{"issue":"1001","key":"10.1016\/j.cellsig.2025.111869_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/pgmj.2008.072629","article-title":"Programmed cell death and cancer","volume":"85","author":"Sun","year":"2009","journal-title":"Postgrad. Med. J."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111869_bb0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41419-024-06712-8","article-title":"Research progress on morphology and mechanism of programmed cell death","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2025.111869_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117150","article-title":"Copper homeostasis and cuproptosis in radiation-induced injury","volume":"178","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.cellsig.2025.111869_bb0045","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00011-022-01672-1","article-title":"Molecular mechanisms of ferroptosis and relevance to inflammation","volume":"72","author":"Deng","year":"2023","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0060","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.2147\/OTT.S232852","article-title":"Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy","volume":"12","author":"Shi","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-020-00230-3","article-title":"Targeting ferroptosis in breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2025.111869_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116971","article-title":"Ferroptosis in thyroid cancer: potential mechanisms, effective therapeutic targets and predictive biomarker","volume":"177","author":"Chen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111869_bb0080","first-page":"5856","article-title":"Ferroptosis: a promising target for cancer immunotherapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-024-07387-7","article-title":"Ferroptosis as a promising targeted therapy for triple negative breast cancer","volume":"207","author":"Mokhtarpour","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0090","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.03.001","article-title":"Mechanisms and therapeutic targets of ferroptosis: implications for nanomedicine design","volume":"14","author":"Zhang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.cellsig.2025.111869_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2024.04.001","article-title":"Unresolved questions regarding cellular cysteine sources and their possible relationships to ferroptosis","volume":"162","author":"Arn\u00e9r","year":"2024","journal-title":"Adv. Cancer Res."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111869_bb0105","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/antiox13060697","article-title":"GSH and Ferroptosis: side-by-side partners in the fight against tumors","volume":"13","author":"Jiang","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cellsig.2025.111869_bb0110","article-title":"Mechanisms and regulations of ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.freeradbiomed.2020.09.008","article-title":"Iron regulatory protein 2 is required for artemether -mediated anti-hepatic fibrosis through ferroptosis pathway","volume":"160","author":"Li","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"14","key":"10.1016\/j.cellsig.2025.111869_bb0120","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CM9.0000000000003169","article-title":"Iron metabolism and arthritis: exploring connections and therapeutic avenues","volume":"137","author":"Zhuo","year":"2024","journal-title":"Chin. Med. J."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0125","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0891-5849(02)01006-7","article-title":"The labile iron pool: characterization, measurement, and participation in cellular processes(1)","volume":"33","author":"Kakhlon","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cellsig.2025.111869_bb0130","article-title":"Understanding the unique mechanism of ferroptosis: a promising therapeutic target","volume":"11","author":"Kong","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The mechanism of ferroptosis and its related diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0140","first-page":"184","article-title":"Lipid metabolism and ferroptosis","volume":"10","author":"Lee","year":"2021","journal-title":"Biology (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0145","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41392-020-00216-5","article-title":"The interaction between ferroptosis and lipid metabolism in cancer","volume":"5","author":"Li","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111869_bb0150","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"issue":"22","key":"10.1016\/j.cellsig.2025.111869_bb0155","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1111\/febs.16059","article-title":"Signaling pathways and defense mechanisms of ferroptosis","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"issue":"21","key":"10.1016\/j.cellsig.2025.111869_bb0160","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J."},{"issue":"17","key":"10.1016\/j.cellsig.2025.111869_bb0165","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of Ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111869_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24094","article-title":"The role of ferroptosis-related genes for overall survival prediction in breast cancer","volume":"35","author":"Jin","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s11658-024-00560-2","article-title":"Role of ferroptosis and ferroptosis-related long non\u2019coding RNA in breast cancer","volume":"29","author":"Xiang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.cellsig.2025.111869_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1506492","article-title":"The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression","volume":"12","author":"Liu","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0185","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/genes14071364","article-title":"Biomarkers in breast cancer: an old story with a new end","volume":"14","author":"Neves Rebello Alves","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0190","first-page":"1","article-title":"A review of prognostic and predictive biomarkers in breast cancer","volume":"23","author":"Tarighati","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cellsig.2025.111869_bb0195","article-title":"Ferroptosis: the emerging player in remodeling triple-negative breast cancer","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2390764","article-title":"Development and validation of Ferroptosis-related lncRNAs as prognosis and diagnosis biomarkers for breast cancer","volume":"2022","author":"Yao","year":"2022","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12885-021-08341-2","article-title":"Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.cellsig.2025.111869_bb0210","doi-asserted-by":"crossref","first-page":"16779","DOI":"10.1007\/s00432-023-05423-5","article-title":"Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer","volume":"149","author":"Cheng","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0215","article-title":"Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0220","article-title":"CCDC134 as a prognostic-related biomarker in breast cancer correlating with immune infiltrates","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"30","key":"10.1016\/j.cellsig.2025.111869_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016528","article-title":"Diagnostic value of MRI combined with ultrasound for lymph node metastasis in breast cancer: protocol for a meta-analysis","volume":"98","author":"Cai","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0230","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/0113892010293337240312051931","article-title":"Exploring the diagnostic and prognostic predictive values of Ferroptosis-related markers in lung adenocarcinoma","volume":"26","author":"Mao","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111869_bb0235","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking ferroptosis in prostate cancer - the road to novel therapies and imaging markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"Suppl. 2","key":"10.1016\/j.cellsig.2025.111869_bb0240","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0245","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41589-022-01038-y","article-title":"Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1","volume":"18","author":"Yang","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111869_bb0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41419-022-05242-5","article-title":"Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111869_bb0255","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10637-017-0474-8","article-title":"Gankyrin as a potential therapeutic target for cancer","volume":"35","author":"Wang","year":"2017","journal-title":"Investig. New Drugs"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-49136-8","article-title":"Gankyrin inhibits ferroptosis through the p53\/SLC7A11\/GPX4 axis in triple-negative breast cancer cells","volume":"13","author":"Lei","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0265","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s12253-019-00612-5","article-title":"SOCS1 and its potential clinical role in tumor","volume":"25","author":"Ying","year":"2019","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0270","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/iub.1728","article-title":"SOCS1 is associated with clinical progression and acts as an oncogenic role in triple-negative breast cancer","volume":"70","author":"Qian","year":"2018","journal-title":"IUBMB Life"},{"issue":"8\u20139","key":"10.1016\/j.cellsig.2025.111869_bb0275","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/carcin\/bgad060","article-title":"SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer","volume":"44","author":"Wang","year":"2023","journal-title":"Carcinogenesis"},{"issue":"0","key":"10.1016\/j.cellsig.2025.111869_bb0280","first-page":"422","article-title":"The role of SRSF1 in cancer","volume":"71","author":"Sok\u00f3\u0142","year":"2017","journal-title":"Postepy Hig. Med. Dosw. (Online)"},{"key":"10.1016\/j.cellsig.2025.111869_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.105055","article-title":"SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9\/GCH1 axis","volume":"292","author":"Song","year":"2024","journal-title":"J. Proteome"},{"key":"10.1016\/j.cellsig.2025.111869_bb0290","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3389\/fonc.2020.00658","article-title":"More than a metabolic enzyme: MTHFD2 as a novel target for anticancer therapy?","volume":"10","author":"Zhu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0295","article-title":"Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.714030","article-title":"Comprehensive analysis of the implication of PGRMC1 in triple-negative breast cancer","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/13697137.2023.2170225","article-title":"PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis","volume":"26","author":"Zhao","year":"2023","journal-title":"Climacteric"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111869_bb0310","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00726-022-03193-x","article-title":"The post-translational modification of Fascin: impact on cell biology and its associations with inhibiting tumor metastasis","volume":"54","author":"Nan","year":"2022","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0315","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41419-022-04579-1","article-title":"Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111869_bb0320","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","article-title":"CDK4\/6 inhibition in cancer: beyond cell cycle arrest","volume":"28","author":"Goel","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0325","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1158\/0008-5472.CAN-23-1749","article-title":"Cotargeting CDK4\/6 and BRD4 promotes senescence and ferroptosis sensitivity in Cancer","volume":"84","author":"Zhu","year":"2024","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0330","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/mco2.97","article-title":"CDK4\/6 inhibitors: a potential therapeutic approach for triple negative breast cancer","volume":"2","author":"Saleh","year":"2020","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0335","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-021-01930-w","article-title":"Efficacy and mechanism of the combination of PARP and CDK4\/6 inhibitors in the treatment of triple-negative breast cancer","volume":"40","author":"Zhu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111869_bb0340","first-page":"947","article-title":"A standardized nomenclature for adenosine deaminases that act on RNA","volume":"3","author":"Bass","year":"1997","journal-title":"RNA"},{"key":"10.1016\/j.cellsig.2025.111869_bb0345","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1146\/annurev.biochem.71.110601.135501","article-title":"RNA editing by adenosine deaminases that act on RNA","volume":"71","author":"Bass","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cellsig.2025.111869_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111258","article-title":"Loss of ADAR1 induces ferroptosis of breast cancer cells","volume":"121","author":"Yin","year":"2024","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0355","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1038\/s41598-023-35517-6","article-title":"Identification of novel interacts partners of ADAR1 enzyme mediating the oncogenic process in aggressive breast cancer","volume":"13","author":"Binothman","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2025.111869_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ctdb.2022.04.003","article-title":"Hedgehog signaling","volume":"149","author":"Ingham","year":"2022","journal-title":"Curr. Top. Dev. Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yexcr.2016.08.012","article-title":"Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells","volume":"349","author":"Alimirah","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104618","article-title":"SUFU suppresses ferroptosis sensitivity in breast cancer cells via hippo\/YAP pathway","volume":"25","author":"Fang","year":"2022","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111869_bb0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrc.2017.8","article-title":"Advances and challenges in targeting FGFR signalling in cancer","volume":"17","author":"Babina","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0380","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-022-30217-7","article-title":"N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer","volume":"13","author":"Zou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111869_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107590","article-title":"FGFR4: a promising therapeutic target for breast cancer and other solid tumors","volume":"214","author":"Levine","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0390","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202009045","article-title":"LNCcation: lncRNA localization and function","volume":"220","author":"Bridges","year":"2021","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0395","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10549-021-06501-3","article-title":"PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer","volume":"193","author":"Qi","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111869_bb0400","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.3390\/cancers15061880","article-title":"LncRNA HCP5-encoded protein regulates ferroptosis to promote the progression of triple-negative breast cancer","volume":"15","author":"Tong","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0405","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2025.111869_bb0410","article-title":"Identification of N6-methyladenosine-associated lncRNAs and analysis of prognostic signature in breast cancer","author":"Gu","year":"2024","journal-title":"Biochem. Genet."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0415","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0420","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","article-title":"Metformin induces ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer","volume":"40","author":"Yang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.cellsig.2025.111869_bb0425","doi-asserted-by":"crossref","first-page":"31041","DOI":"10.18632\/oncotarget.16055","article-title":"Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5","volume":"8","author":"Al-Jameel","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0430","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18212","article-title":"SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxidation","volume":"28","author":"He","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cellsig.2025.111869_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116077","article-title":"G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis","volume":"222","author":"Sun","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0440","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fchem.2014.00113","article-title":"Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer","volume":"2","author":"Bandyopadhyay","year":"2014","journal-title":"Front. Chem."},{"key":"10.1016\/j.cellsig.2025.111869_bb0445","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.cellsig.2025.111869_bb0450","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1042\/CS20160935","article-title":"Curcumin mediates anticancer effects by modulating multiple cell signaling pathways","volume":"131","author":"Kunnumakkara","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261370","article-title":"Curcumin suppresses tumorigenesis by ferroptosis in breast cancer","volume":"17","author":"Cao","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellsig.2025.111869_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154921","article-title":"Sculponeatin a promotes the ETS1-SYVN1 interaction to induce SLC7A11\/xCT-dependent ferroptosis in breast cancer","volume":"117","author":"Peng","year":"2023","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0465","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/ptr.7780","article-title":"Peiminine regulates bone-fat balance by canonical Wnt\/\u03b2-catenin pathway in an ovariectomized rat model","volume":"37","author":"Gu","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.cellsig.2025.111869_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102323","article-title":"Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling","volume":"87","author":"Yi","year":"2024","journal-title":"Tissue Cell"},{"issue":"Pt A","key":"10.1016\/j.cellsig.2025.111869_bb0475","article-title":"Levistilide a ameliorates neuroinflammation via inhibiting JAK2\/STAT3 signaling for neuroprotection and cognitive improvement in scopolamine-induced Alzheimer\u2019s disease mouse model","volume":"124","author":"Ni","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0480","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2147\/DDDT.S374328","article-title":"Levistilide a induces Ferroptosis by activating the Nrf2\/HO-1 signaling pathway in breast Cancer cells","volume":"16","author":"Jing","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0485","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jps.2600690313","article-title":"Antitumor agents XLI: effects of eupaformosanin on nucleic acid, protein, and anaerobic and aerobic glycolytic metabolism of Ehrlich ascites cells","volume":"69","author":"Hall","year":"1980","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.cellsig.2025.111869_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174970","article-title":"Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer","volume":"924","author":"Wei","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.cellsig.2025.111869_bb0495","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.3390\/ijms21165920","article-title":"Ursolic acid-based derivatives as potential anti-cancer agents: an update","volume":"21","author":"Khwaza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3892\/or.2024.8753","article-title":"Ursolic acid inhibits the proliferation of triple-negative breast cancer stem-like cells through NRF2-mediated ferroptosis","volume":"52","author":"Yang","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2025.111869_bb0505","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","article-title":"Progress in tumor-associated macrophage (TAM)-targeted therapeutics","volume":"114","author":"Ngambenjawong","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","article-title":"HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0515","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12885-019-5295-z","article-title":"Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer","volume":"19","author":"Mumin","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22039","article-title":"Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1\u03b1","volume":"32","author":"Wang","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6409","key":"10.1016\/j.cellsig.2025.111869_bb0525","doi-asserted-by":"crossref","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0530","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1245\/s10434-015-4934-0","article-title":"Predictive value of neutrophil\/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer","volume":"23","author":"Asano","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"9\u201310","key":"10.1016\/j.cellsig.2025.111869_bb0535","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s10495-023-01866-w","article-title":"Neutrophil extracellular traps mediate TLR9\/Merlin axis to resist ferroptosis and promote triple negative breast cancer progression","volume":"28","author":"Yao","year":"2023","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0540","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001","volume":"30","author":"Hamid","year":"2019","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0545","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139434","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","volume":"131","author":"Jiang","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0550","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188890","article-title":"GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0560","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/imm.13683","article-title":"Deubiquitinase inhibitor PR-619 potentiates colon cancer immunotherapy by inducing ferroptosis","volume":"170","author":"Wu","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.cellsig.2025.111869_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103560","article-title":"Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy","volume":"71","author":"Sha","year":"2021","journal-title":"EBioMedicine"},{"issue":"15","key":"10.1016\/j.cellsig.2025.111869_bb0570","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202305546","article-title":"High intensity focused ultrasound-driven nanomotor for effective Ferroptosis-immunotherapy of TNBC","volume":"11","author":"Yu","year":"2024","journal-title":"Adv. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0575","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/02656736.2014.969789","article-title":"Emerging HIFU applications in cancer therapy","volume":"31","author":"Maloney","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.cellsig.2025.111869_bb0580","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231157193","article-title":"Ablative therapies for breast cancer: state of art","volume":"22","author":"Carriero","year":"2023","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.cellsig.2025.111869_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0590","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.cellsig.2025.111869_bb0595","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","article-title":"Molecular definitions of autophagy and related processes","volume":"36","author":"Galluzzi","year":"2017","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0600","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13046-018-0880-6","article-title":"HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0605","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111869_bb0610","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg4993","article-title":"ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation","volume":"9","author":"Jia","year":"2023","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.cellsig.2025.111869_bb0615","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1158\/0008-5472.CAN-10-4322","article-title":"Combination of PI3K\/mTOR inhibitors: antitumor activity and molecular correlates","volume":"71","author":"Mazzoletti","year":"2011","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111869_bb0620","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1080\/15548627.2016.1212786","article-title":"ATG3-dependent autophagy mediates mitochondrial homeostasis in pluripotency acquirement and maintenance","volume":"12","author":"Liu","year":"2016","journal-title":"Autophagy"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111869_bb0625","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/ijms20123066","article-title":"Decreased autophagy impairs decidualization of human endometrial stromal cells: a role for ATG proteins in endometrial physiology","volume":"20","author":"Mestre Citrinovitz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2025.111869_bb0630","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","article-title":"The role of Atg proteins in autophagosome formation","volume":"27","author":"Mizushima","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111869_bb0635","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","article-title":"Autophagy-dependent ferroptosis: machinery and regulation","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111869_bb0640","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bbagen.2017.05.019","article-title":"Ferroptosis: role of lipid peroxidation, iron and ferritinophagy","volume":"1861","author":"Latunde-Dada","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"51","key":"10.1016\/j.cellsig.2025.111869_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.cellsig.2025.111869_bb0650","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbad004","article-title":"Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy","volume":"10","author":"Liu","year":"2023","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.cellsig.2025.111869_bb0655","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038225","article-title":"Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111869_bb0660","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111869_bb0665","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2967\/jnumed.114.143842","article-title":"Dose escalation and dosimetry of first-in-human \u03b1 radioimmunotherapy with 212Pb-TCMC-trastuzumab","volume":"55","author":"Meredith","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111869_bb0670","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.2967\/jnumed.108.051771","article-title":"Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate","volume":"49","author":"Costantini","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.cellsig.2025.111869_bb0675","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2147\/IJN.S240293","article-title":"Emerging antineoplastic biogenic gold nanomaterials for breast cancer therapeutics: a systematic review","volume":"15","author":"Saravanan","year":"2020","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111869_bb0680","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10876-018-01491-7","article-title":"Emerging Theranostic biogenic silver nanomaterials for breast cancer: a systematic review","volume":"30","author":"Barabadi","year":"2019","journal-title":"J. Clust. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0685","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41467-022-29018-9","article-title":"Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis","volume":"13","author":"Wu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111869_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0695","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40364-024-00558-0","article-title":"Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling","volume":"12","author":"Tan","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cellsig.2025.111869_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111760","article-title":"Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11\/GPX4\/ACSL4 axis","volume":"131","author":"Ma","year":"2025","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111869_bb0705","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mc.23861","article-title":"HMGB3 contributes to anti-PD-1 resistance by inhibiting IFN-\u03b3-driven ferroptosis in TNBC","volume":"64","author":"Luo","year":"2025","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cellsig.2025.111869_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217232","article-title":"The deubiquitinase OTUD5 stabilizes SLC7A11 to promote progression and reduce paclitaxel sensitivity in triple-negative breast cancer","volume":"604","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.cellsig.2025.111869_bb0715","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cac2.12319","article-title":"PKC\u03b2II-ACSL4 pathway mediating ferroptosis execution and anti-tumor immunity","volume":"42","author":"Lei","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.cellsig.2025.111869_bb0720","article-title":"Ferroptosis in liver cancer: a key role of post-translational modifications","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188365","article-title":"Ferroptosis-mediated immune responses in cancer","volume":"14","author":"Qi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2025.111869_bb0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"issue":"34","key":"10.1016\/j.cellsig.2025.111869_bb0735","doi-asserted-by":"crossref","first-page":"eaba8968","DOI":"10.1126\/sciadv.aba8968","article-title":"Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis","volume":"6","author":"Verma","year":"2020","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111869_bb0740","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111869_bb0745","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41420-024-01868-w","article-title":"The potential role of hydrogen sulfide in cancer cell apoptosis","volume":"10","author":"Gao","year":"2024","journal-title":"Cell Death Dis."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T22:34:29Z","timestamp":1756247669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":149,"alternative-id":["S0898656825002840"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111869","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of ferroptosis in breast cancer: Molecular mechanisms and therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111869"}}